Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02741193 · ClinicalTrials.gov registry record · NA

Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS)

A NA study of Epilepsy, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
2
Enrollment target
1
Study location

NCT02741193: Completed NA study of Epilepsy, sponsored by NYU Langone Health.

NCT02741193 is a NA study of Epilepsy that has completed, run by NYU Langone Health. The registered enrollment target is 2 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02741193, a NA study of Epilepsy, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
2 participants
Enrollment target
1
Study location

Study Summary

The aim of the study is to examine the degree of concordance between presurgical neuronavigation guided TMS (nTMS) and direct cortical stimulation (DCS) in identifying hand motor cortex in adults undergoing epilepsy surgery. Navigated transcranial magnet stimulation (nTMS), MagStim RapidStim2 Magnetic stimulation will be delivered to hand primary motor cortex, with positive and negative functional sites determined through surface electromyography (EMG). The study will involve patients ages 12-60 years, with planned neurosurgery involving implantation of intracranial subdural electrodes including over the precentral gyrus. Navigated transcranial magnet stimulation (nTMS), MagStim RapidStim2 Magnetic stimulation will be delivered to hand primary motor cortex, with positive and negative functional sites determined through surface electromyography (EMG). The primary outcome measure will be spatial correlation between topographic maps of hand motor representation obtained through nTMS compared to direct, extra-operative cortical stimulation performed as part of routine clinical care. A secondary outcome measure will be safety and tolerability of TMS in the epilepsy patients.

Conditions Studied

Epilepsy

Interventions

  • DEVICE The Magstim Rapid2,

Study Locations (1)

New York

  • New York University Langone Medical Center - New York

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2016-09-10
Est. Completion 2023-02-23
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT02741193 record still lists

NCT02741193 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which The Magstim Rapid2, is the first listed.

NCT02741193 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02741193 about?

NCT02741193 is a clinical study titled "Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS)". The aim of the study is to examine the degree of concordance between presurgical neuronavigation guided TMS (nTMS) and direct cortical stimulation (DCS) in identifying hand motor cortex in adults undergoing epilepsy surgery. Navigated transcranial magnet stimulation (nTMS), MagStim RapidStim2 Magne...

What is the current status of trial NCT02741193?

This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2016-09-10. Estimated completion is 2023-02-23.

What conditions does trial NCT02741193 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT02741193?

The interventions under investigation include: The Magstim Rapid2, (DEVICE).

Who is sponsoring clinical trial NCT02741193?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02741193 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02741193's enrollment target sits among peer trials

2 160th of 160 higher than 1 of 160 other Epilepsy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT02741193, the US trial registry maintained by the National Library of Medicine. NCT02741193 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.